Stockreport

Piper Sandler Remains Bullish on Compass Therapeutics (CMPX) [Yahoo! Finance]

Compass Therapeutics, Inc.  (CMPX) 
PDF Inc. (NASDAQ:CMPX) received a rating update from Piper Sandler analyst Biren Amin on October 27, who maintained a Buy rating on the stock with a $12 price target. Is C [Read more]